CovidResearchTrials by Shray Alag

CovidResearchTrials Covid 19 Research using Clinical Trials (Home Page)

New QIAstat-Dx fully automatic multiple PCR detection platformWiki

Developed by Shray Alag
Clinical Trial MeSH HPO Drug Gene SNP Protein Mutation


Correlated Drug Terms (2)

Name (Synonyms) Correlation
drug647 Prazosin Wiki 1.00
drug775 Standard of care Wiki 0.35

Correlated MeSH Terms (1)

Name (Synonyms) Correlation
D018352 Coronavirus Infections NIH 0.06

Correlated HPO Terms (0)

Name (Synonyms) Correlation

There is one clinical trial.

Clinical Trials

1 Development and Verification of a New Coronavirus Multiplex Nucleic Acid Detection System

Our project intends to independently develop a fully enclosed rapid detection system for a total of 22 pathogens, including SARS-CoV-2, on the basis of the QIAstat-Dx fully automatic multiple PCR detection platform. The reasonably designed experiments are used to verify the performance of the cartridge detection and prove its clinical application value. The 22 pathogens tested in this project includes 4 coronavirus subtypes, A / B flu, parainfluenza virus, respiratory syncytial virus, etc., which is of great significance for the differential diagnosis of similar patients.

NCT04311398 COVID-19 Diagnostic Test: New QIAstat-Dx fully automatic multiple PCR detection platform
MeSH:Coronavirus Infections

Primary Outcomes

Measure: Sensitivity， spectivity turnaround time of the New QIAstat-Dx fully automatic multiple PCR detection platform

Time: 3 months

No related HPO nodes (Using clinical trials)